Asymptomatic ST-segment depression during exercise testing and the risk of sudden cardiac death in middle-aged men: A population-based follow-up study

European Heart Journal

Volumn 30, Issue 5, 2009, Pages 558-565

  Laukkanen, Jari A ^a,b   Mäkikallio, Timo H ^b,c   Rauramaa, Rainer ^a,d   Kurl, Sudhir ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b LAPLAND CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF OULU   (Finland)

^d KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Exercise electrocardiography; Risk factors; Sudden death

Indexed keywords

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; ELECTROCARDIOGRAPHY; EXERCISE TEST; FOLLOW UP; HEART DEATH; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALIDITY; PRIORITY JOURNAL; RISK FACTOR; SMOKING; ST SEGMENT DEPRESSION; SUDDEN DEATH; BODY MASS; EPIDEMIOLOGY; EXERCISE; FINLAND; METHODOLOGY; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS;

ADULT; BODY MASS INDEX; DEATH, SUDDEN, CARDIAC; DIABETES MELLITUS, TYPE 2; ELECTROCARDIOGRAPHY; EPIDEMIOLOGIC METHODS; EXERCISE; EXERCISE TEST; FINLAND; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PROGNOSIS; SMOKING;

EID: 63349090519     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehn584     Document Type: Article

References (42)

1. Huikuri HV, Castellanos A, Myerburg RJ. Sudden death due to cardiac arrhythmias. N Engl J Med 2001;345:1473-1482.
2. Muller D, Agrawal R, Hans-Richard A. How sudden is cardiac death? Circulation 2006;114:1146-1150.
3. Fowler-Brown A, Pignone M, Pletcher M, Tice JA, Sutton SF, Lohr KN. Exercise tolerance testing to screen for coronary heart disease: a systematic review for the technical support for the U.S. Preventive Services Task Force. Ann Intern Med 2004;140:W9-W24.
4. Fletcher GF, Balady GJ, Amsterdam EA, Chaitman B, Eckel R, FlegJ, Froelicher VF, Leon AS, Pina IL, Rodney R, Simons-Morton DA, Williams MA, Bazzarre T. Exercise standards for testing and training: a statement for healthcare professionals from the American Heart Association. Circulation 2001;104:1694-1740.
5. Laukkanen JA, Kurl S, Lakka TA, Tuomainen TP, Rauramaa R, Salonen R, Eranen J, Salonen JT. Exercise-induced silent myocardial ischemia and coronary morbidity and mortality. J Am Coll Cardiol 2001:38:72-79.
6. Detrano R, Gianrossi R, Mulvihill D, Lehmann K, Dubach P, Colombo A, Froelicher V. Exercise-induced ST segment depression in the diagnosis of multivessel coronary disease: a meta analysis. J Am Coll Cardiol 1989;14:1501-1508.
7. Weiner DA, Ryan TJ, McCabe CH, Ng G, Chaitman BR, Sheffield LT, Tristani FE, Fisher LD. Significance of silent myocardial ischemia during exercise testing in patients with coronary artery disease. AmJ Cardiol 1987;59:725-729.
8. Bruce RA, Hossack KF, DeRouen TA, Hofer V. Enhanced risk assessment for primary coronary heart disease events by maximal exercise testing: 10 years' experience of Seattle Heart Watch.J Am Coll Cardiol 1983;2:563- 573.
9. Lauer M, Froelicher ES, Williams M, Kligfield P. Exercise testing in asymptomatic adults: A statement for professionals from the American heart association council on clinical cardiology, subcommittee on exercise, cardiac rehabilitation, and prevention. Circulation 2005;112:771-776.
10. Almeda FQ, Kason TT, Nathan S, Kavinsky CJ. Silent myocardial ischemia: concepts and controversies. Am J Med 2004;116:112-118.
11. Mark DB, Hlatky MA, Califf RM, Morris JJ Jr, Sisson SD, McCants CB, Lee KL, Harrell FE Jr, Pryor DB. Painless exercise ST deviation on the treadmill: long term prognosis. J Am Coll Cardiol 1989;14:885-892.
12. Miranda CP, Lehmann KG, Lachterman B, Coodley EM, Froelicher VF. Comparison of silent and symptomatic ischemia during exercise testing in men. Ann Intern Med 1991;114:645-656.
13. Falcone C, De Servi S, Poma E, Campana C, Sciré A, Montemartini G, Specchia G. Clinical significance of exercise-induced silent myocardial ischemia in patients with coronary artery disease. J Am Coll Cardiol 1987;9:295-299.
14. Bonow RO, Bacharach SL, Green MV, LaFreniere RL Epstein SE. Prognostic implications of symptomatic versus asymptomatic (silent) myocardial ischemia induced by exercise in mildly symptomatic and in asymptomatic patients with angiographically documented coronary artery disease. Am J Cardiol 1987;60:778-783.
15. Rautaharju PM, Prineas RJ, EiflerWJ, FurbergCD, NeatonJD, Crow RS, StamlerJ, Cutler JA. Prognostic value of exercise electrocardiogram in men at high risk of future coronary heart disease: Multiple Risk Factor Interventional Trial experience. J Am Coll Cardiol 1986;8:1-10.
16. Ekelund L-G, Suchindran CM, McMahon RP, Heiss G, Leon AS, Romhilt DW, Rubenstein CL, Probstfield JL, Ruwitch JF. Coronary heart disease morbidity and mortality in hypercholesterolemic men predicted from an exercise test: the Lipid Research Clinics Coronary Primary Prevention Trial. J Am Coll Cardiol 1989;14:556-563.
17. Fleg JL, Gerstenblith G, Zonderman AB, Becker LC, Weisfeldt ML, Costa PT Jr, Lakatta EG. Prevalence and prognostic significance of exercise-induced silent myocardial ischemia detected by thallium scintigraphy and electrocardiography in asymptomatic volunteers. Circulation 1990;81:428-436.
18. Lakka TA, Venäläinen JT, Rauramaa R, Salonen R, Tuomilehto J, Salonen JT. Relation of leisure-time physical activity and cardiorespiratory fitness to the risk of acute myocardial infarction in men. N Engl J Med 1994;330:1549-1554.
19. Salonen JT, Nyyssönen K, Korpela H, Tuomilehto J, Seppänen R, Salonen R. High. stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 1992;86:803-811.
20. 3 subfractions, and the risk of acute myocardial infarction: a prospective population study in eastern Finnish men. Circulation 1991;84:129-139.
21. Tunstall-Pedoe H, Kuulasmaa K, Amoyel P, Arveiler D. Rajakangas AM, Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project registration procedures, event rates and case fatality rates in 38 populations from 21 countries in 4 continents. Circulation 1994;90:583-612.
22. Kannel WB, Abbott RD. Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham Study. N Engl J Med 1984;311: 1144-1147.
23. Deanfield JE, Maseri A, Selwyn AP, Ribeiro P, Chierchia S, Krikler S, Morgan M. Myocardial ischaemia during daily life in patients with stable angina: its relation to symptoms and heart rate. Lancet 1983;1:753-758.
24. Maseri A. Role of coronary artery spasm in symptomatic and silent myocardial ischemia. J Am Coll Cardiol 1987;9:249-262.
25. Deedwania PC, Nelson JR. Pathophysiology of silent myocardial ischemia during daily life. Hemodynamic evaluation by simultaneous electrocardiographic and blood pressure monitoring. Circulation 1990;82:1296-1304.
26. Klein J. Chao SY, Berman DS, Rozanski A. Is 'silent' myocardial ischemia as severe as symptomatic ischemia? The analytical effect of patient selection biases. Circulation 1994;89:1958-1966.
27. Giagnoni E, Secchi MB, Wu SC, Morabito A, Oltrona L Mancarella S, Volpin N, Fossa L, Bettazzi L, Arangio G. Prognostic value of exercise EKG testing in asymptomatic normotensive subjects. A prospective matched study. N Engl J Med 1983; 309:1085-1089.
28. Smith SC Jr, Amsterdam E, Balady GJ, Bonow RO, Fletcher GF, Froelicher V, Heath G, Limacher MC, Maddahi J, Pryor D, Redberg RF, Roccella E, Ryan T, Smaha L, Wenger K. Prevention conference V. Beyond secondary prevention: identifying the high-risk patient for primary prevention: tests for silent and inducible ischemia. AHA scientific statement. Circulation 2000;101:e12-e16.
29. Karnegis JN, Matts J, Tuna N, Amplatz K. Comparison of exercise-positive with recovery-positive treadmill graded exercise test. Am J Cardiol 1987;60: 544-547.
30. Savage MP, Squires LS, Hopkins JT, Raichlen JS, Park CH, Chung EK. Usefulness of ST-segment depression as a sign of coronary artery disease when confined to the postexercise recovery period. Am J Cardiol 1987;60:1405-1406.
31. Lachterman B, Lehmann KG, Abrahamson D, Froelicher VF. 'Recovery only' ST segment depression predictive accuracy of the exercise test. Ann Intern Med 1990;112:11-16.
32. Rywik TM, Zink RC, Gittings NS, Khan AA, Wright JG, O'Connor FC, Fleg JL. Independent prognostic significance of ischemic ST-segment response limited to recovery from treadmill exercise in asymptomatic subjects. Circulation 1998; 97:2117-2122.
33. Sharma B, Asinger R, Francis GS, Hodges M, Wyeth RP. Demonstration of exercise-induced painless ischemia in out-of-hospital ventricular fibrillation. Am J Cardiol 1987;59:740-745.
34. Barsky AJ, Hochstrasser B, Coles NA, Zisfein J, O'Donnell C, Eagle KA. Silent myocardial ischemia. Is the person or the event silent? JAMA 1990;264:1132-1135.
35. Dimsdale JE, Hartley LH, Guiney T, Ruskin JN, Greenblatt D. Postexercise peril: plasma catecholamines and exercise. JAMA 1984;251:630-632.
36. Fleg JL, Tzankoff SP, Lakatta EG. Age-related augmentation of plasma catecholamines during dynamic exercise in healthy males.J Appl Physiol 1985;59:1033-1039.
37. Josephson M, Wellens HJJ. Implantable defibrillators and sudden cardiac death. Circulation 2004;109:2685 - 2691.
38. Froelicher VF. Screening with the exercise test: time for a guideline change? Eur Heart J 2005:26:1353-1354.
39. Erikssen G, Bodegard J, Bjornholt JV, Liestol K, Thelle SD, Erikssen J. Exercise testing of healthy men in a new perspective: from diagnosis to prognosis. Eur Heart J 2004;25:978-986.
40. Erne P, Schoenenberger AW, Zuber M, Burckhardt D, Kiowski W, Dubach P, Resink T, Pfisterer M. Effects of anti-ischaemic drug therapy in silent myocardial ischaemia type I: the Swiss Interventional Study on Silent lschaemia type I (SWISSI I): a randomized, controlled pilot study. Eur Heart J 2007;28:2110- 2117.
41. Boden WE, O'Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, Knudtson M, Dada M, Casperson P, Harris CL, Chaitman BR, Shaw L, Gosselin G, Nawaz S, Title LM, Gau G, Blaustein AS, Booth DC, Bates ER, Spertus JA, Berman DS, Mancini GB, Weintraub WS. COURAGE Trial Research Group. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007;356:1503-1516.
42. Erne P, Schoenenberger AW, Burckhardt D, Zuber M, Kiowski W, Buser PT. Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: the SWISSI II randomized controlled trial. JAMA 2007;297: 1985-1991.